Teva Pharmaceuticals USA, Inc recalls Claravis (isotretinoin capsule
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Failed Impurities/Degradation Specifications: Out of specification for specific impurity Tretinoin
- Products
-
- Claravis (isotretinoin capsule
- Where it was sold
-
Nationwide in the USA, Puerto Rico and Virgin Islands
Nationwide
- Units affected
- 5,101 cartons
- About this recall
- Claravis (isotretinoin capsule, USP), 10 mg, Packaged as a) 100-count carton, NDC 0555-1054-56, with 10x10 blister packs NDC 0555-1054-60; b) 30-count carton, NDC 0555-1054-86, with 3X10 blister pack NDC 0555-1054-60; Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454.